Heron Therapeutics | HRTX - Interest Income


Heron Therapeutics reported $433K in Interest Income for its fiscal quarter ending in December of 2021.





Interest Income Change Date
ALKERMES USD 8.54M 3.59M Mar/2026
Alnylam Pharmaceuticals USD 26.63M 2.05M Dec/2025
Amarin USD 3.37M 3.37M Dec/2024
Arrowhead Research USD 9.69M 637K Dec/2025
Eisai JPY 3.11B 783M Mar/2024
Esperion Therapeutics USD -0.15 0.18 Sep/2024
GlaxoSmithKline GBP 22M 96M Mar/2026
Heron Therapeutics USD 433K 277K Dec/2021
Insmed USD 765K 55K Sep/2024
Ligand Pharmaceuticals USD 6.39M 2.52M Dec/2025
Merck USD 69M 27M Dec/2025
Nektar Therapeutics USD -0.18 0.07 Sep/2024
Pacira USD 2.3M 6.24M Dec/2025
Regeneron Pharmaceuticals USD 193.3M 18.2M Dec/2025
Ultragenyx Pharmaceutical USD 6.51M 649K Dec/2025
Veracyte USD 3.48M 545K Sep/2025
Vertex Pharmaceuticals USD 114.8M 7.1M Mar/2026